Hemoblastoses occupy the first place in the structure of the incidence of malignant tumors in children [1]. Currently, the five-year overall survival rate of children with hemoblastosis has increased significantly and exceeded 80% [2]. Despite the progress made in the treatment of malignant neoplasms of hematopoietic and lymphoid tissues in children, there remains a risk … Continue reading Rehabilitation of children with hemoblastosis at various stages of antitumor treatment